Skip to content
Medium cut-off hemodialysis in multiple myeloma-associated cast nephropathy: A single-center experience
All contributors

Onconephrology contributor

Rini, Brian I

Primarily Anti-VEGF / TKI renal effects#35 of 47 recognized
  • #1 in Anti-VEGF / TKI renal effects
11
Clinical papers
1,903
Citations (iCite)
6 / 2
First / senior author
2008–2024
Active years

Output over time

Clinical corpus papers per year — peak 2 in 2015.

  • 2008: 1 paper
  • 2009: 1 paper
  • 2010: 1 paper
  • 2011: 1 paper
  • 2012: 1 paper
  • 2014: 1 paper
  • 2015: 2 papers
  • 2018: 2 papers
  • 2024: 1 paper
20082024

Subfield mix

Clinical papers by onconephrology subfield (a paper can count in more than one).

Anti-VEGF / TKI renal effects11

Frequent collaborators

Other recognized contributors who most often share corpus papers with Rini (shared-paper count).

Chen, Helen X2

Agents they study

Catalog agents whose clinical kidney literature lists Rini among the leading contributors.

Sunitinib6Axitinib3

Verify

Representative recent papers, and this author’s full PubMed bibliography.

PMID 37916303 (opens PubMed in a new tab)PMID 29530667 (opens PubMed in a new tab)PMID 29113767 (opens PubMed in a new tab)PMID 26320662 (opens PubMed in a new tab)PMID 25813447 (opens PubMed in a new tab)PMID 24842548 (opens PubMed in a new tab)All papers on PubMed

A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,329-article corpus (regenerated 2026-08-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.